ConductScience.org, home

Paper7909557

Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.

Shannon HE and 12 others. J Pharmacol Exp Ther, 1994. Cited by 149 papers, by iCite.

Cite this record

ConductScience Library. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors. Papers, record 7909557. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7909557

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1994
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
149
iCite
Relative citation ratio, by iCite
4.85
iCite
Revised in PubMed
2015-01-06
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shannon HEH E
2Bymaster FPF P
3Calligaro DOD O
4Greenwood BB
5Mitch CHC H
6Sawyer BDB D
7Ward JSJ S
8Wong DTD T
9Olesen PHP H
10Sheardown MJM J
11Swedberg MDM D
12Suzdak PDP D
13Sauerberg PP

Source PubMed

Download CSV of authors

Topics33

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ParasympathomimeticsMajor topic
PyridinesMajor topic
Receptors, MuscarinicMajor topic
ThiadiazolesMajor topic
Animals
Body Temperature
CHO Cells
Cricetinae
Depression, Chemical
Gastrointestinal Motility
Guinea Pigs
Heart Atria
Heart Rate
Humans
Hydrolysis
Ileum
In Vitro Techniques
Inositol Phosphates
Male
Muscle Contraction
Muscle, Smooth
Myocardial Contraction
Neurotransmitter Agents
Rabbits
Radioligand Assay
Rats
Rats, Sprague-Dawley
Receptors, Neurotransmitter
Salivation
Transfection
Tremor
Urinary Bladder
Vas Deferens

Source PubMed

Download CSV of topics

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 149 citations.

PMIDTitleJournalYearIn PapersSource
42556870Altered Functional Connectivity in the Reward Circuit in Betel Quid-Dependent Chewers.Addict Biol2026https://conductscience.org/library/papers/42556870PubMed
42450007Xanomeline-Trospium Validates Muscarinic Agonism as an Effective Non-Dopaminergic Treatment for Schizophrenia.Int J Mol Sci2026https://conductscience.org/library/papers/42450007PubMed
41633901Targeting muscarinic receptors for treating schizophrenia.Neurotherapeutics2026https://conductscience.org/library/papers/41633901PubMed
41343242Protein-protein interaction-interfering peptide rescues dysregulated NMDA receptor signaling.JCI Insight2026https://conductscience.org/library/papers/41343242PubMed
41147362Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference?J Psychopharmacol2025https://conductscience.org/library/papers/41147362PubMed
41052274Antipsychotic drugs at 75: the past, present, and future of psychosis management.Br Med Bull2025https://conductscience.org/library/papers/41052274PubMed
40574777Targeting muscarinic receptors in schizophrenia treatment: Novel antipsychotic xanomeline/trospium chloride.World J Psychiatry2025https://conductscience.org/library/papers/40574777PubMed
40165106Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials.BMC Psychiatry2025https://conductscience.org/library/papers/40165106PubMed
39871564Advancements in Managing Schizophrenia through Classical Approaches, Mechanisms, and Deep Brain Stimulation.Curr Pharm Des2025https://conductscience.org/library/papers/39871564PubMed
39857669Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds.Biomedicines2025https://conductscience.org/library/papers/39857669PubMed
39143241A golden age of muscarinic acetylcholine receptor modulation in neurological diseases.Nat Rev Drug Discov2024https://conductscience.org/library/papers/39143241PubMed
38904739Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment.Clin Drug Investig2024https://conductscience.org/library/papers/38904739PubMed
38839931Normative modelling of molecular-based functional circuits captures clinical heterogeneity transdiagnostically in psychiatric patients.Commun Biol2024https://conductscience.org/library/papers/38839931PubMed
38317082M1 cholinergic signaling in the brain modulates cytokine levels and splenic cell sub-phenotypes following cecal ligation and puncture.Mol Med2024https://conductscience.org/library/papers/38317082PubMed
37835460Selective Activation of M1 Muscarinic Receptors Attenuates Human Colon Cancer Cell Proliferation.Cancers (Basel)2023https://conductscience.org/library/papers/37835460PubMed
37193547Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia.Neuropsychiatr Dis Treat2023https://conductscience.org/library/papers/37193547PubMed
36983018
Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia.
Int J Mol Sci2023https://conductscience.org/library/papers/36983018PubMed
36973270Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system.Transl Psychiatry2023https://conductscience.org/library/papers/36973270PubMed
36782010Structural basis of efficacy-driven ligand selectivity at GPCRs.Nat Chem Biol2023https://conductscience.org/library/papers/36782010PubMed
36414626Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study.Transl Psychiatry2022https://conductscience.org/library/papers/36414626PubMed

See all 50 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7909557

GET https://conductscience.org/api/papers/v1/7909557/cited_by?page=2